[Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
D000222:Adaptation, Physiological / Q000187:drug effects*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008134:Long-Term Care; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood; D014376:Tuberculosis / Q000188:drug therapy / Q000201:enzymology*
D000995:Antitubercular Agents; D004977:Ethambutol; D000637:Transaminases; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Adaptationserscheinungen unter Kombinierter antituberkulöser Langzeitbehandlung